[Featured Stock] SysWok Shows Early Strength Among 'COVID-19 Diagnostic Kit Related Stocks'

[Asia Economy Reporter Park So-yeon] Syswork, a stock related to COVID-19 diagnostic kits, is showing strong performance in the early trading session.

As of 9:08 AM on the 9th, Syswork is trading at 2,830 KRW on the KOSDAQ market, up 400 KRW (16.46%) from the previous day.

With the increase in COVID-19 confirmed cases, Syswork, acquired by VVV which develops diagnostic kits, has attracted investors' attention.

VVV, which developed the COVID-19 diagnostic kit 'Sampinut' jointly with Celltrion, became the largest shareholder of Syswork by acquiring it in August last year.

Following the announcement that Syswork would begin contract manufacturing of VVV's COVID-19 antigen diagnostic kits from the first half of this year, and the same day the product received emergency approval from the US FDA, Syswork was classified as a stock related to diagnostic kits.

Syswork has a market capitalization of 210.4 billion KRW and ranks 517th on the KOSDAQ. The number of listed shares is 74,356,685, with a par value of 100 KRW per share.

Syswork's main business is manufacturing and selling cleanroom control systems, heating and cooling air conditioning systems, and ventilation control systems.

Its products are supplied to and operated in semiconductor and display production lines (FAB) of top global companies such as Samsung Electronics, Samsung Display, LG Display, and SK Hynix.

This content was produced with the assistance of AI translation services.